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1025-64 Long-Term Clinical Outcome of Catheter-Based 
Intramyocardial Autologous Bone Marrow Cells 
Implantation in Patients With End-Stage Coronary 
Artery Disease
Hung-Fat Tse, Sukumaran Thambar, Yok-Lam Kwong, John KF Chan, Gladys Lo, Chi-Lai 
Ho, Wai-Hong Chen, Grey Bellan, Chu-Pak Lau, University of Hong Kong, Queen Mary 
Hospital, Hong Kong, Hong Kong, Hunter Heart-Lung Research Guild, John Hunter 
Hospital, Newcastle, Australia
Background: Recent experimental studies have demonstrated bone marrow cell (BMC)
implantation induces neovascularization and improves heart function after myocardial inf-
arction. Despite enthusiasm for these pioneering clinical trials, the long-term safety and
efficacy of implanting autologous BMCs into the human myocardium remains a major
concern. The purpose of this study was to evaluate the long-term clinical outcome of
implanting autologous BMCs into patients (pts) with end-staged coronary artery disease
(CAD). Methods: We evaluated the long-term clinical outcome in 12 pts (mean age:
60±10 yrs, 11 males) with end-staged CAD who underwent catheter-based autologous
BMC cells implantation guided by electromechanical mapping. A mean of 1.1±0.2 ml of
mononuclear cells (106 cells/ ml, 2.9±2.6% of CD34+ cells) was injected to 16 ischemic
regions. No elevation in cardiac enzyme or pericardial effusion observed after the proce-
dure. 2 pts died of stroke (8 mths) and myocardial infarction (20 mths), respectively. After
23±6 mths follow-up, there were significant improvement in NYHA class (2.1±0.8 vs
2.8±0.5), angina class (2±0.9 vs 3.3±0.5) and quality of life (SF-36: 65±14 vs 51±15)
compared to baseline (all p<0.05). Stress SPECT-sestamibi studies demonstrated signif-
icant improvement in myocardial perfusion in 9/12 (75%) pts at 6 mths. Magnetic reso-
nance imaging at baseline, 3 and 6 mths after procedure showed no evidence of
intramyocardial tumor formation, myocardial damage or change in left ventricular function
(58±9 vs 59±11 vs 58±16%, p>0.05). Furthermore, no patient developed symptomatic
ventricular tachyarrhythmias nor detected by 24 hrs Holter at 3 and 6 mths follow-up.
Conclusions: Our study demonstrate that BMC implantation using a percutaneous cath-
eter procedure is safe and feasible in pts with “end-staged” CAD and improve their symp-
toms and quality of life. The absence of any acute procedural complications or long-term
sequalae, including ventricular arrhythmia, myocardial damage or development of
intramyocardial tumor, are encouraging in terms of the safety and feasibility of this novel
catheter-based cellular transplantation procedure for severe CAD.
1025-65 First Human Heart Myoblast Allograft
Peter Law, Cell Transplants International, LLC, Memphis, TN
Background
Endomyocardial myoblast injections deposited myofilaments and augmented contractility.
We report here the world’s first myoblast allografts into two CAD patients.
Methods
Quadriceps biopsy (2.18g) from a 20-year-old, pathogen-free male was cultured comply-
ing cGMP/ISO 9001 to yield 3.64x109 myoblasts that were 98.3% pure (desmin immuno-
positive), 91.5% viable, potent in myotube formation, and negative for endotoxin, myco-
plasma, sterility, and gram stain. Male subjects, aged 63 and 49, developed atherosclero-
sis, coronary artery disease, chronic myocardial infarction, stable angina Functional
Class IV (CCS), and arterial hypertension II (risk 4). PET with 18FDG revealed scars with
hibernated myocardium in LV septal, apical, and anterior/posterior wall regions. Echocar-
diography showed regional akinesis/hypokinesis, LVEF being 41% and 38%. On 1/17/
2003, they received 18/19 injections and 1.1/1.2 billion myoblasts (108 /mL), respectively.
The 0.5 mL injections were placed between infarcted and viable myocardium after CABG
on ice-chilled, non-beating hearts. Subjects took oral cyclosporine (5 to 7 mg/kg body
weight per day) for 8 weeks. Doses were adjusted to maintain whole blood trough level at
about 250 ng/mL. 24-hour Holter EKG was monitored.
Results
The subjects recovered with no rash or high fever. Both developed arrhythmia and extra-
systoles that were eliminated with Amiodarone. Rejection symptom was not observed
despite cyclosporine discontinuation. Between 3 to 8-months follow-up, both were in sta-
ble condition with angina at Class I-II. Echocardiography showed 14.6% and 10.5%
increases in LVEF with no local hypokinesis. SPECT with 30 mCi 99mTc-tetrophosphomin
demonstrated positive dynamics, LVEF increases, and reduction in perfusion defect
areas during exercise and rest. 18FDG accumulation was equable throughout LV myocar-
dium; glucose metabolism sustained.
Conclusions
The feasibility and preliminary safety/efficacy shown in these allografts provide a new
potential therapy for heart failure and its prevention, with virtually unlimited cell availability
and 2-month immunosuppression.
1025-66 Biological Markers of the Restenosis
Laurent Payot, Gilles Montalescot, Rémi Choussat, Michel Slama, Jean-Luc Dubois 
Randé, Jean-Philippe Metzger, J. Thillet, C. Bal, L. Drouet, Centre Hospitalier 
Universitaire Pitié-Salpétrière (AP-HP), Paris, France
Background:
The incidence of coronary restenosis 6 months following angioplasty is 25 to 45%
according to selected definitions. The detection of restenosis by non-invasive means
remain particularly disappointing. The purpose of this study was to evaluate the evolution
of potential biological markers of restenosis after angioplasty and identify whether some
are predictive of restenosis.
Methods and Results:
A total of 229 consecutive patients with chronic stable angina or stabilised unstable
angina, were recruited in five centers. Measurements of fibrinogen, CRP, tPA Ag, VWfAg,
f PAI-1
f VIIc, f VIIa, f VII Ag, TAT, D-Dimer, Ceruloplasmine, lipoprotein(a) were performed in a
central laboratory before and immediately after, two months, four months and six months
after angioplasty. The criterion of evaluation was restenosis defined clinically and angio-
graphically. A systematic clinical and angiographic follow-up was obtained in all patients.
The relations between biological variables and definitions of restenosis were assessed
by univariate and multivariate analyses. A prolonged elevation of CRP and fibrinogen
was observed over the first four months of follow-up with some decrease at two month
and re ascension at four months( 32% increase of CRP between the second and fourth
month p=0.11; 4% increase of the fibrinogen, p=0.0022).A similar evolution was
observed for the plasma levels of f VIIc, f VII a, f VII Ag, f PAI. All the variables return to
baseline levels at six months. These biological profiles are consistent with the restenosis
process which occurs mainly between 2 and 4 months. However, after multivariate analy-
sis, no biological variable was significantly and consistently (with regards to the various
definitions) associated with restenosis, at any time point.
Conclusion: Ours findings suggest that inflammation occurs and can persist for 4 months
after angioplasty but no biological variable was found to be independently predictive of
clinical and/or angiographic restenosis.
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1026-55 In Vitro Detection and Quantification of High Intensity 
Transient Signals by Using Intracoronary Doppler 
Ultrasound: A New Approach to Detect Coronary 
Microembolization
Philipp Bahrmann, Marcel Wagner, Jens Hopfe, Markus Ferrari, Andreas Voss, Gerald S. 
Werner, Hans R. Figulla, Friedrich-Schiller-University, Jena, Germany, University of 
Applied Sciences, Jena, Germany
Introduction: Brief, high-intensity transient signals (HITS) in the Doppler velocity spec-
trum correspond to microemboli made of thrombotic and non-thrombotic material in labo-
ratory models. Transcranial doppler detection of HITS in the cerebral circulation was the
first clinical application to study the pathogenesis of embolism in humans. We used a
commercially available Doppler ultrasound device dedicated for the use in coronary arter-
ies for the validation of HITS detection in an in vitro model using artificial embolic parti-
cles.
Methods and Results: HITS were defined by the following characteristics: (1) high-
intensity signal, (2) short duration, (3) unidirectional within the Doppler velocity spectrum
and (4) accompanied by a "snap", "chirp" or "moan" on the audio output. An experimental
flow circuit was made of a polyethylene tube with an internal diameter of 3 mm. A flow
pattern similar to a human coronary artery was obtained by a roller pump. We positioned
a 0.014'' guidewire with a 12 MHz pulsed Doppler ultrasound transducer mounted on its
tip into the circuit. The guidewire was connected to a console (FloWire/FloMap System®,
Endosonics) that employed a 128-point fast Fourier transform for signal intensity mea-
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surement. The pulse repetition frequency was set at 100 Hz. The circuit was filled with
starch solution to obtain a blood like pulsatile flow signal. Sand particles with a mean size
of 300 µm (range, 100 to 500 µm) were introduced into the circuit. The particles were fil-
tered out after passing the guidewire and counted under a microscop. The Doppler veloc-
ity spectrum was recorded on Super VHS tape and analysed offline. Two observers had
to agree independently that the signal met the identification criteria of HITS. There was a
significant positive linear correlation between particle count and number of HITS (R²=.94,
P<.001).
Conclusions: Using a commercially available intracoronary Doppler ultrasound device,
embolic particles can be detected as HITS in the laboratory model. Intracoronary Dop-
pler ultrasound may present a feasible approach for the detection of coronary microem-
bolization during coronary interventions.
1026-56 Patterns of Lesion Calcification in Infarct-Related 
Arteries: An Intravascular Ultrasound Analysis of 250 
Patients With Acute Myocardial Infarction
Jun-ichi Kotani, Gary S. Mintz, Prithviraj B. Rai, Constantine C. Pappas, John C. Pappas, 
Augusto D. Pichard, Lowell F. Satler, William O. Suddath, John R. Laird, Jr., Kenneth M. 
Kent, Neil J. Weissman, Washington Hospital Center, Washington, DC
Background: Calcium is considered part of end-stage atherosclerosis. In patients with
chronic stable angina undergoing intervention, 73% of target lesions contain calcium
(70% of which is superficial) with a mean arc of 115° (47% >1 quadrant) located mostly at
the site of the minimum lumen area. Previous studies suggested that acute myocardial
infarction (MI) lesions are less calcified than chronic stable angina lesions.
Method: We assessed calcium within infarct-related arteries (IRA) in 250 consecutive
patients (mean age 62±12 years, 172 males) within 2 months of the onset of an MI. The
arc, length, and location of calcium were measured using pre-intervention intravascular
ultrasound (IVUS).
Results: Calcium was observed in 222 (88.9%) infarct-related arteries (166 patients had
>1 quadrant of calcium). In 152 IRAs calcium was remote from the culprit lesion. In 194
culprit lesions that contained calcium (of which only 68, 27.2% contained >1 quadrant),
calcium was seen at the minimum lumen site in 122 and remote from the minimum lumen
site in 77. Overall, the arc of calcium measured 62.6±91.8° at the minimum lumen site;
calcium within the lesion, but remote from the minimum lumen site, measured
72.3±91.8º; and IRA calcium not located in the culprit lesion measured 81.4±90.9º
(P<0.0001). However, when only image slices containing calcium were included, the arc
of calcium measured 131.1±93.1º versus 122.7±76.6º versus 134.0±80.7º (P=0.4).
Importantly, calcium distribution was significantly different among these three locations.
Calcium at the minimum lumen site was mostly deep (in 60.6%) while calcium elsewhere
in the IRA was mostly superficial (76.3%) as was calcium elsewhere in the culprit lesion
(P<0.0001).
Conclusion: IVUS shows that calcium in infarct-related arteries is less often in the culprit
lesion and, when present in the culprit lesion, is deep and remote from the site of the
minimum lumen area; decidedly different from the location and severity of calcium in
chronic stable angina. This different pattern of calcium in MI patients may either contrib-
ute to the instability of a culprit lesion or may be the end product of the culprit lesion's
necrotic core.
1026-57 Coronary Atherosclerosis Is More Advanced in the 
Patients With Acute Myocardial Infarction Than 
Unstable Angina
Yasunori Ueda, Isamu Mizote, Tomohito Ohtani, Yuji Okuyama, Masaya Usami, Atsushi 
Hirayama, Kazuhisa Kodama, Osaka Police Hospital, Osaka, Japan
Background The formation of intra-coronary yellow plaques can be assessed by angios-
copy, and is advanced in patients with acute myocardial infarction (AMI). However, the
difference in the extent of coronary atherosclerosis between unstable angina (UA) and
AMI, which are both acute coronary syndrome, has not been clarified.
Methods Angioscopic examinations were performed in 54 patients with AMI and 22
patients with UA. The prevalence of yellow plaques and thrombus and the color grade of
yellow plaques were evaluated for the whole culprit artery. The color grade was deter-
mined as 0 (white), 1 (slight yellow), 2 (yellow), or 3 (intensive yellow) for each plaque
detected. Angioscopically, atherosclerosis was assessed by number of yellow plaques
(N), maximum (MC) color grade of observed yellow plaques, and the prevalence of
thrombus (PT) in the non-culprit segments.
Results Mean color grade (1.9 vs. 1.7, p=ns) of yellow plaques and the prevalence of
thrombus (93% vs 77%, p=ns) at the culprit lesions were not different between AMI and
UA. However, atherosclerosis assessed by N (mean, 1.8 vs 1.2, p=0.04), MC (3.1 vs. 2.3,
p=0.008), and PT (39% vs. 10%, p=0.01) was significantly advanced in patients with AMI
than UA.
Conclusions Although plaques at culprit lesions of UA and AMI had similar appearance,
angioscopically determined atherosclerosis is more advanced in patients with AMI than
UA.
1026-58 The Effectiveness of Distal-Protect Devices in Patients 
With Acute Coronary Syndromes: The Relationship 
Between Coronary Thrombus and Thrombolysis in 
Myocardial Infarction Frame Counts After Percutaneous 
Coronary Interventions
Kentaro Okamatsu, Kyoichi Mizuno, Shunta Sakai, Shinya Yokoyama, Takayoshi Ohba, 
Koji Seimiya, Masamichi Takano, Shigenobu Inami, Junko Sano, Noritake Hata, Nippon 
Medical School, Chiba Hokusoh Hospital, Chiba, Japan
Previous reports have been showed that large vessels with lipid-pool or stent implanta-
tions are high risk for no-reflow phenomenon.However, few studies have actually
assessed the role of coronary thrombus on the coronary blood flow after percutaneous
coronary interventions (PCI) for acute coronary syndromes (ACS), because coronary
thrombus can be precisely evaluated with neither angiography nor intravascular ultra-
sounds. Using angioscopy, which is more sensitive and specific method to identify coro-
nary thrombus, we investigated the relationship between coronary thrombus and the
corrected TIMI frame counts (CTFC) and confirmed the effectiveness of a distal-protect
device. Methods: We studied 69 ACS patients treated with emergent PCI. All patients
underwent coronary angioscopy before PCI, and were divided into three groups, Large
group (n=25), in which a large amount of thrombus was observed at culprit lesion, Small
group (n=36), in which a small amount of thrombus was observed, and Protect group
(n=8), in which a large amount of thrombus was observed and we used a distal-protect
device during PCI. Furthermore, we divided patients according to the presence of yellow
plaque that had lipid-pool, and stent implantation. We measured the CTFC of the culprit
vessels based on post-PCI cineangiograms. Results: There were no significant differ-
ences in the CTFC between vessels with yellow plaques and without yellow plaques, and
between vessels with stent and without stent. However, the CTFC in the Large group
(23.5±15.8) were significantly higher than those in the Small group (16.8±7.7) and in the
Protect group (12.9±2.9; p= 0.023). Moreover, the CTFC in the Protect group was,
although not statically significant, lower than that in the Small group. Conclusions: Our
study disclosed that the amount of coronary thrombus, but not lipid pool, was a crucial
factor for affecting the coronary blood flow after catheter interventions in patients with
ACS. A further our finding suggests that we can prevent the no-reflow phenomenon with
efficacious thrombus-removal devices.
1026-59 Elevated High-Sensitivity C-Reactive Protein Was 
Associated With Coronary Artery Remodeling in 
Patients With Unstable Angina
Takahiro Tsuji, Masato Nakamura, Itaru Yokouchi, Atsushi Funatsu, Tsuyoshi Ono, 
Masanori Shiba, Masamichi Wada, Raisuke Iijima, Rintarou Nakajima, Masato 
Yamamoto, Hidehiko Hara, Hisao Hara, Takashi Yoshitama, Tarou Tsunoda, Kaoru Sugi, 
Toho University Ohashi Hospital, Tokyo, Japan
BACKGROUND:Chemical marker such as high-sensitivity C-reactive protein (hsCRP)
and cardiac troponin T (cTnT) are of clinical significance in the assessment of risk of
acute coronary syndromes(ACS). However, the association of coronary lesion morphol-
ogy and chemical marker are not well examined.
Purpose: In this study, we tried to define the relationship between lesion morphology and
the value of hsCRP, and cTnT.
METHODS:We investigated 74 consecutive patients with unstable angina who under-
went preintervention IVUS. With respect to hsCRP, and cTnT, the cutoff values were
0.3mg/dl for hsCRP and 0.1ng/ml for cTnT. The patients were divided into 4 groups:
group 1, 9 patients with hsCRP positive and cTnT positive; group 2, 7 patients with
hsCRP negative and cTnT positive; group 3, 18 patients with hsCRP positive and cTnT
negative; group 4, 41 patients with hsCRP negative and cTnT negative. Coronary remod-
eling evaluation with the use of IVUS was compared between 4 groups.
RESULTS:Remodeling index was significantly higher in group 1 (p<0.0001 between
group 2 or 3 or 4 vs group 1). We observed plaque rupture: 3 patients (33%) in group 1, 3
patients (43%) in group 2, 3 patients (17%) in group 3, 4 patients (10%) in group 4. There
was no difference in the incidence of plaque rupture between hsCRP positive group and
hsCRP negative group, however plaque rupture was seen more frequently in cTnT posi-
tive group than in cTnT negative group (p=0.02). CONCLUSIONS:This study indicates
that baseline levels of hsCRP and cTnT are independently related to instability of coro-
nary plaque in patients with unstable angina, and elevated cTnT may be a marker of
plaque rupture. 
1026-60 Effects of Functional Coronary Collateral Flow on the 
Incidence of Right Ventricular Infarction After Primary 
Angioplasty in Patients With Acute Inferior Myocardial 
Infarction
Koichi Tamita, Takashi Akasaka, Atsushi Yamamuro, Minako Katayama, Shunichirou Kaji, 
Kazuaki Tanabe, Kunihiko Nagai, Tomoko Tani, Shigefumi Morioka, Tsutomu Takagi, 
Kobe General Hospital, Kobe, Japan, Kawasaki Medical School, Kurashiki, Japan
Background: Right ventricular (RV) infarction occurs in conjunction with inferior myocar-
dial infarction (MI) caused by proximal occlusion of the right coronary artery. The relation-
ship between functional collateral blood flow and RV infarction remains unclear.
Intracoronary pressure measurement is a new technique to provide accurate and quanti-
tative information about the collateral circulation, and it can be easily applied during per-
cutaneous coronary interventions. The purpose of this study was to assess the relation
between pressure-derived fractional collateral flow (PDCF) and the incidence of RV inf-
arction in patients with acute inferior MI.
Methods: The study population consisted of 26 patients with a first acute inferior MI (pain
onset <12h) caused by proximal right coronary artery occlusion who underwent coronary
stenting. Preinfarction angina was defined as one or more episodes of typical chest pain
